Clinical Trials Microdosing Topical Treatment 
Canna Law Blog
NOVEMBER 15, 2021
Microdose hosted its annual psychedelics conference in Miami last week (appropriately titled “Wonderland”). This is a topic we have covered regularly on the Canna Law Blog, most recently by Mason Marks , here. Ketamine clinics are flourishing. Psychedelics are not cannabis.
Canna Law Blog
NOVEMBER 27, 2021
Medicines and Healthcare Products Regulatory Agency for one of its DMT products for the treatment of major depressive disorder. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. Compass Pathways Releases Phase 2B Trial Results.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
DECEMBER 12, 2022
Scientists are hopeful that psychedelics might have more of a curative effect when it comes to mental health than many existing treatment options; meaning that unlike most psychiatric medications, psychedelics may be able to prompt long-term changes to our mental state with only a few doses. What is microdosing? Are psychedelics safe?
Cannabis Law Report
SEPTEMBER 10, 2019
Upcoming studies will determine the effectiveness of psilocybin as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa and alcohol use in people with major depression. Mushrooms as Medicine?
The Cannigma
JUNE 24, 2021
These natural alternatives may also be effective as part of a daily “microdosing” regiment. While more human clinical trials are needed, the current evidence suggests there may be potential therapeutic benefits for the following ailments: Chronic pain — the most common reason people turn to medical cannabis in the United States today.
Cannabis Law Report
NOVEMBER 24, 2019
Future studies will explore psilocybin’s effectiveness as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa, and alcohol use in people with major depression. Participate in Our Studies.
CannaMD
OCTOBER 7, 2019
This logic also addresses the question of how medical marijuana and cannabis-based drugs like Marinol can increase appetite and weight gain in patients suffering from condition or treatment-related anorexia or wasting, but still increase weight loss in other patients.
Expert insights. Personalized for you.
98 
Let's personalize your content